Pigment Cell Melanoma Res (2013) 26(4):51826
The Food and Drug Administration (FDA) approved Ozempic as a treatment for type 2 diabetes in 2017
GLP-1 receptor agonist medications, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro), can be injected into the upper arm as an approved subcutaneous injection site
The medication tells your body to produce more insulin, so youre less likely to crave sugary foods
As we will be unable to correct ASM participation status, to avoid potential errors, clinicians should confirm and provide necessary updates to their PECOS information if they believe that their current specialty designation does not reflect their actual clinical practice
It is essential to acknowledge that these excipients can differ among different manufacturers